SPRINKLR INC-A (CXM)

US85208T1079 - Common Stock

7.19  -0.1 (-1.37%)

Fundamental Rating

5

Overall CXM gets a fundamental rating of 5 out of 10. We evaluated CXM against 282 industry peers in the Software industry. CXM has an average financial health and profitability rating. CXM has a correct valuation and a medium growth rate.



5

1. Profitability

1.1 Basic Checks

CXM had positive earnings in the past year.
In the past year CXM had a positive cash flow from operations.
In the past 5 years CXM reported 4 times negative net income.
Of the past 5 years CXM 4 years had a positive operating cash flow.

1.2 Ratios

CXM has a better Return On Assets (5.14%) than 77.14% of its industry peers.
CXM's Return On Equity of 10.79% is amongst the best of the industry. CXM outperforms 82.14% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.65%, CXM belongs to the top of the industry, outperforming 81.43% of the companies in the same industry.
Industry RankSector Rank
ROA 5.14%
ROE 10.79%
ROIC 6.65%
ROA(3y)-4.45%
ROA(5y)-6.93%
ROE(3y)-8.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 6.54%, CXM is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
With a decent Operating Margin value of 5.31%, CXM is doing good in the industry, outperforming 72.14% of the companies in the same industry.
The Gross Margin of CXM (74.26%) is better than 63.93% of its industry peers.
CXM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.31%
PM (TTM) 6.54%
GM 74.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.33%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CXM is destroying value.
The number of shares outstanding for CXM has been increased compared to 1 year ago.
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 2.38 indicates that CXM is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.38, CXM is in line with its industry, outperforming 51.43% of the companies in the same industry.
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.38
ROIC/WACC0.66
WACC10.06%

2.3 Liquidity

CXM has a Current Ratio of 1.61. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.61, CXM is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 1.61 indicates that CXM should not have too much problems paying its short term obligations.
The Quick ratio of CXM (1.61) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.61

6

3. Growth

3.1 Past

CXM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.57%, which is quite impressive.
CXM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.71%.
Measured over the past years, CXM shows a very strong growth in Revenue. The Revenue has been growing by 23.70% on average per year.
EPS 1Y (TTM)69.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)14.71%
Revenue growth 3Y23.7%
Revenue growth 5YN/A
Sales Q2Q%10.5%

3.2 Future

The Earnings Per Share is expected to grow by 16.26% on average over the next years. This is quite good.
CXM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.98% yearly.
EPS Next Y-3.13%
EPS Next 2Y8.64%
EPS Next 3Y10.69%
EPS Next 5Y16.26%
Revenue Next Year8.24%
Revenue Next 2Y6.33%
Revenue Next 3Y6.65%
Revenue Next 5Y8.98%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.44, CXM is valued on the expensive side.
CXM's Price/Earnings ratio is rather cheap when compared to the industry. CXM is cheaper than 83.21% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 31.76, CXM is valued a bit cheaper.
A Price/Forward Earnings ratio of 15.62 indicates a correct valuation of CXM.
Based on the Price/Forward Earnings ratio, CXM is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.74, CXM is valued a bit cheaper.
Industry RankSector Rank
PE 18.44
Fwd PE 15.62

4.2 Price Multiples

CXM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CXM is cheaper than 84.29% of the companies in the same industry.
82.14% of the companies in the same industry are more expensive than CXM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.53
EV/EBITDA 17.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.64%
EPS Next 3Y10.69%

0

5. Dividend

5.1 Amount

CXM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (10/17/2024, 1:17:13 PM)

7.19

-0.1 (-1.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.82B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 18.44
Fwd PE 15.62
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 10.79%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.31%
PM (TTM) 6.54%
GM 74.26%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.61
Quick Ratio 1.61
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)69.57%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-3.13%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.71%
Revenue growth 3Y23.7%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y